Low diagnostic and predictive value of anti-dsDNA antibodies in unselected patients with recent onset of rheumatic symptoms: Results from a long-term follow-up Scandinavian multicentre study

Scandinavian Journal of Rheumatology

Volumn 42, Issue 4, 2013, Pages 311-316

  Compagno, M ^a   Jacobsen, S ^b   Rekvig, O P ^c   Truedsson, L ^d   Heegaard, N H ^e   Nossent, J ^c   Jonsen A ^a   Jacobsen, R S ^b   Eilertsen, G O ^c   Sturfelt, G ^a   Bengtsson, A A ^f  

^a LUND UNIVERSITY   (Sweden)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d University and Regional Laboratories Region Skåne ^*  (Sweden)

^e STATENS SERUM INSTITUT   (Denmark)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA ANTIBODY; MEPROSCILLARIN;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTHROPATHY; ARTICLE; CONNECTIVE TISSUE DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOLOGY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; COHORT STUDIES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RHEUMATIC DISEASES; RISK ASSESSMENT; SCANDINAVIA; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84880249582     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2013.765032     Document Type: Article

References (19)

1. Heidenreich U, Mayer G, Herold M, Klotz W, Stempfl Al-Jazrawi K, Lhotta K. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis. Lupus 2009;18: 1276-80.
2. Ho A, Magder LS, Barr SG, Petri M. Decreases in anti-doublestranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis Rheum 2001;44:2342-9. (Pubitemid 32977502)
3. Lopez-Hoyos M, Cabeza R, Martinez-Taboada VM, Crespo J, SanSegundo D, Blanco R, et al. Clinical disease activity and titers of anti-dsDNA antibodies measured by an automated immunofluorescence assay in patients with systemic lupus erythematosus. Lupus 2005;14:505-9. (Pubitemid 41161079)
4. Swaak AJ, Groenwold J, Aarden LA, Statius van Eps LW, Feltkamp EW. Prognostic value of anti-dsDNA in SLE. Ann Rheum Dis 1982;41:388-95. (Pubitemid 12038906)
5. Bootsma H, Spronk P, Derksen R, de Boer G, Wolters-Dicke H, Hermans J, et al. Prevention of relapses in systemic lupus erythematosus. Lancet 1995;345:1595-9.
6. Touma Z, Gladman DD, Tulloch-Reid D, Toloza SM, Ibanez D, Fortin PR, et al. Burden of autoantibodies and association with disease activity and damage in systemic lupus erythematosus. Clin Exp Rheumatol 2010;28:525-31.
7. Swaak T, Smeenk R. Detection of anti-dsDNA as a diagnostic tool: A prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA). Ann Rheum Dis 1985;44:245-51. (Pubitemid 15112838)
8. Gripenberg M, Helve T. Outcome of systemic lupus erythematosus. A study of 66 patients over 7 years with special reference to the predictive value of anti-DNA antibody determinations. Scand J Rheumatol 1991;20:104-9.
9. Manoussakis MN, Garalea KL, Tzioufas AG, Moutsopoulos HM. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera. Clin Rheumatol 1988;7:465-9. (Pubitemid 19250292)
10. Haugbro K, Nossent JC, Winkler T, Figenschau Y, Rekvig OP. Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: The role of analytical diversity. Ann Rheum Dis 2004;63:386-94. (Pubitemid 38453304)
11. Launay D, Schmidt J, Lepers S, Mirault T, Lambert M, Kyndt X, et al. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus. Clin Chim Acta 2010;411:959-64.
12. Chiang M, Chia D, Barnett EV. Evaluation of fluorescent antinuclear antibody assays, Crithidia luciliae substrate, and single-stranded DNA-binding capacity in diagnosis of four rheumatic diseases. J Clin Microbiol 1982;15:684-7. (Pubitemid 12135627)
13. Ballou SP, Kushner I. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus. Clin Exp Immunol 1979;37:58-67. (Pubitemid 9201946)
14. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
15. Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007; 56:2344-51. (Pubitemid 47173582)
16. Arbuckle MR, James JA, Kohlhase KF, Rubertone MV, Dennis GJ, Harley JB. Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus. Scand J Immunol 2001;54:211-19. (Pubitemid 32592348)
17. Eriksson C, Kokkonen H, Johansson M, Hallmans G, Wadell G, Rantapaa-Dahlqvist S. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011;13:R30.
18. Smeenk R, Hylkema M. Detection of antibodies to DNA: A technical assessment. Mol Biol Rep 1992;17:71-9.
19. Swaak AJ, Groenwold J, Aarden LA, Feltkamp TE. Detection of anti-dsDNA as diagnostic tool. Ann Rheum Dis 1981;40:45-9. (Pubitemid 11153067)